Earlier this month, in a speech to Oxford University students, the former CEO of Microsoft, Steve Ballmer, said that the future is “cloud and devices”. In this case, the Sponsors of clinical trials should be looking to adopt technology solutions today as an investment in future efficiency and cost cutting measures. In this week’s blog post, ARITHMOS looks at technology trends that are shaping the clinical trial environment and offers solutions that can be implemented to start improving trial performance.
1. JOIN THE CLOUD.
If your company has not considered cloud-based technologies for clinical trial operations, it’s time to get on board. EDC systems, pharmacovigilance systems and reporting tools are offered in both Software as a Service (SaaS) and Platform as a Service (PaaS) mode meaning there is no installation or purchase of hardware or software which significantly reduces operational costs.
Cloud computing can increase employee productivity and collaboration since they can access the application from anywhere and communicate in real time via the application rather than meetings and emails.
Cloud computing can also be more secure than software and hardware installation. Service providers can ensure high levels of security, run security patches and perform validation and maintenance services.
Solutions for Clinical Trials: ARITHMOS can provide several cloud-based solutions for Sponsors of clinical trials. We have a cloud-based EDC system, Symphony, which simplifies data collection and management. eCRFs can be designed independently without particular need for technical skills. Additionally, ARITHMOS provides pharmacovigilance database and reporting solutions as Software as a Service (SaaS) meaning your safety data is available in real-time and in compliance with regulatory standards. ARITHMOS also offers clinical data reporting solutions in cloud mode so Sponsors can analyze study data and reports from multiple sources.
2. PICK YOUR DEVICE.
Approximately one in every five people worldwide has a smartphone, and 6% of the world’s population is using tablets which are demonstrating a faster adoption rate than smartphones. So, why not use smartphones and tablets in clinical trial operations?
The best example of devices in the clinical trial environment is smartphones and tablets as ePRO devices. ePRO takes the burden off the subject and allows clinical trial leaders to have more control over the situation. Devices can be programmed to send reminders to subjects so they fill out diaries with real time data and submit data in real time. Moreover, studies have demonstrated that subjects have a greater sense of privacy with ePRO devices. Subjects might be hesitant to respond honestly on a paper form knowing that various people will read their answers.
Lastly, clinical trial leaders no longer have to manage paper questionnaires with the risk of losing clinical data or having to interpret illegible responses.
Solutions for Clinical Trials: ARITHMOS has experience implementing ePRO systems using iPhone, Blackberry and Android as well as tablets such as the iPad and Samsung Galaxy Tab. These devices have proven to be intuitive and increase patient compliance as well as provide applications with medical and health related information. It is also possible to implement therapeutic area specific devices. ARITHMOS has used a spirometric device for respiratory trials and glucometers for diabetes trials.
3. CONTEXTUALIZE YOUR DATA
In 2014, there is no reason Sponsors shouldn’t have real-time access to clinical data in a clear way. Clinical data visualization tools are available to create efficient and customized reports. These tools manage vast amounts of data and present them in visual tables and graphs to simplify analysis and make important decisions about study progress.
Solutions for Clinical Trials: ARITHMOS works with the best Business Intelligence providers to offer a state of the art visualization tool. We can then integrate data visualization tools with your handheld devices for real-time access to clinical data anytime, anywhere.
4. BE SOCIAL.
Social media is a technological area that is still growing in clinical trials. How can Sponsors and Investigators connect directly with patients through various social media outlets such as Facebook, Twitter or even LinkedIn? Will there be a future social media hub just for clinical trials?
Social Media may also play a key role if the European Union moves forward with its data transparency initiative. How can companies present data in a clear and transparent way using social media tools?
Can social media eventually be used for signal detection and other pharmacovigilance needs?
Sponsors should begin analyzing the potential of social media and the impact it may have on clinical trial operations and marketed products.